Septerna Inc (SEPN)の価格はいくらですか

Septerna Inc (SEPN)の価格は$40.61です

Septerna Inc (SEPN)の時価総額は何ですか

Septerna Inc (SEPN)の時価総額は$1.83Bです

Septerna Inc（SEPN）EPS（1株当たり利益）

Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves’ disease and thyroid eye disease. In addition, it focuses on other therapeutic areas, including neurology, women’s health, cardiovascular disease, and respiratory disease. It has global collaboration and license agreement with Novo Nordisk to discover, develop and commercialize multiple potential oral small molecule therapies for metabolic-related diseases based on certain specified molecular targets. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.

年	EPS	変化
提供された日付のデータは十分ではありません。

年

EPS

変化

提供された日付のデータは十分ではありません。

企業	EPS	EPSの差	国
Vertex Pharmaceuticals Incorporated VRTX.US	$17.32	-	US
Argenx SE ARGX.US	$27.74	-	NL
CSL Limited CSL.AX	$-5.29	-	AU
Moderna, Inc. MRNA.US	$-7.98	-	US
Lonza Group AG LONN.SW	-	-	CH

企業

EPS

EPSの差

国

Vertex Pharmaceuticals Incorporated

VRTX.US

$17.32

Argenx SE

ARGX.US

$27.74

CSL Limited

CSL.AX

$-5.29

Moderna, Inc.

MRNA.US

$-7.98

Lonza Group AG

LONN.SW

Septerna Inc

SEPN

カテゴリー